Leading Russian pharma producers call for additional state support

Leading Russian pharmaceutical companies have called on the national government to provide additional support that will be used for the launch of full cycle production and the increase of exports, according to recent statements of producers and some senior officials of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent.

Several months ago, the Russian national government announced its plans to double exports of domestic drugs during the next several years. These plans, however, were criticized by the majority of local producers, who said implementation of these plans is almost impossible, due to small volume of support provided by the state to domestic drugmaker and some serious market obstacles.

Dmitry Borisov. director general of Biocad, one of Russia’s leading drugmakers, says: “We are locked inside the domestic market. The launch of a drug to foreign markets takes up to six years, while the increase of exports at such volumes could be considered more as a dream.”